Hematological Oncology

Published by: Wiley Blackwell  

People

  1. Horwitz
    Horwitz
  2. Yahalom
    Yahalom
  3. Palomba
    Palomba
  4. Salles
    Salles
  5. Moskowitz
    Moskowitz
  6. Imber
    Imber
  7. Zelenetz
    Zelenetz
  8. Kumar
    Kumar
  9. Noy
    Noy
  10. Hamlin
    Hamlin

Groups

  1. Hematologic Malignancies, Division of (170)
  2. Department of Medicine (167)
  3. Center for Hematologic Malignancies (134)
  4. Lymphoma (110)
  5. Survivorship Research (55)
  6. Population Sciences Research Program (38)
  7. Radiation Oncology, Department of (35)
  8. Sloan Kettering Institute Postdocs (31)
  9. Executive Committee, Center for Hematologic Malignancies (26)
  10. Epidemiology and Biostatistics (24)
Search Within
Formats
  1. Meeting Abstract (175)
  2. Journal Article (13)
  3. Review (5)
  4. Conference Paper (4)
  5. Research Letter (2)
Groups
  1. Hematologic Malignancies, Division of (170)
  2. Department of Medicine (167)
  3. Center for Hematologic Malignancies (134)
  4. Lymphoma (110)
  5. Survivorship Research (55)
  6. Population Sciences Research Program (38)

More Groups

People
  1. Steven Horwitz (38)
  2. Joachim Yahalom (34)
  3. Maria Palomba (30)
  4. Gilles Salles (28)
  5. Alison Moskowitz (23)
  6. Anas Younes (22)

More People

Years
  1. 2025 (3)
  2. 2024 (2)
  3. 2023 (66)
  4. 2022 (3)
  5. 2021 (32)
  6. 2020 (2)

More Years

Publishers
  1. Wiley Blackwell (199)

Results (199)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Brentuximab vedotin vs physician's choice in CTCL patients from the Phase 3 ALCANZA study: Analysis of outcomes by CD30 expression
    Meeting Abstract

    Kim, Y. H.; Prince, H. M.; Whittaker, S.; Horwitz, S. M.; Duvic, M.; Scarisbrick, J.; Quaglino, P.; Zinzani, P. L.; Wolter, P.; Bechter, O.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Improved survival outcomes for patients with extra-nodal NK/T lymphoma: Data from 140 patients prospectively registered in the international T-cell project
    Meeting Abstract

    Fox, C. P.; Bellei, M.; Manni, M.; Kim, S. J.; Ko, Y. H.; Shustov, A. R.; Cabrera, M. E.; Chiattone, C. S.; Horwitz, S. M.; Spina, M.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Interim report from a phase 2 multicenter study of tazemetostat, an EZH2 inhibitor, in patients with relapsed or refractory B-cell non-Hodgkin lymphomas
    Meeting Abstract

    Morschhauser, F.; Salles, G.; McKay, P.; Tilly, H.; Schmitt, A.; Gerecitano, J.; Johnson, P.; Le Gouill, S.; Dickinson, M. J.; Fruchart, C.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Outcome of curative radiotherapy for localised follicular lymphoma in the era of (18)F-FDG PET-CT staging: An internal collaborative study on behalf of ILROG
    Meeting Abstract

    Brady, J. L.; Binkley, M. S.; Hajj, C.; Chelius, M. R.; Chau, K. W.; Levis, M.; Choi, S.; Suh, C.; Hardy, S. J.; Constine, L. S.; more...
    Hematological Oncology (2017)

    Fulltext@MSK | Save
  • Clinical applications of genome studies
    Conference Paper

    Younes, A.
    Wiley Blackwell (2017)

    Fulltext@MSK | Save
  • High-dose cytarabine as salvage therapy for relapsed or refractory acute myeloid leukemia-is more better or more of the same?
    Journal Article

    Wolach, O.; Itchaki, G.; Bar-Natan, M.; Yeshurun, M.; Ram, R.; Herscovici, C.; Shpilberg, O.; Douer, D.; Tallman, M. S.; Raanani, P.
    Hematological Oncology (2016)

    Fulltext@MSK | Save
  • XII. Therapeutic exploitation of autologous T-cell activation in B-cell lymphoma
    Journal Article

    Younes, A.
    Hematological Oncology (2015)

    Fulltext@MSK | Save
  • XIV. The rationale for combining targeted and biological anti-lymphoma drugs
    Journal Article

    Younes, A.
    Hematological Oncology (2013)

    Fulltext@MSK | Save
  • Phenotypic characterization of ‘non‐T, non‐B’ acute lymphoblastic leukemia by a new panel (BL) of monoclonal antibodies
    Journal Article

    Al‐Katib, A.; Wang, C. Y.; Bardales, R.; Koziner, B.
    Hematological Oncology (1985)

    Fulltext@MSK | Save

    • Hematological Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Hematological Oncology 02780232 John Wiley & Sons
    Hematological Oncology 0278-0232 John Wiley & Sons
    Hematological Oncology 0278-0232 Wiley Blackwell
    Hematological Oncology 02780232 John Wiley & Sons
    Hematological Oncology 02780232 Unknown
    Hematological Oncology 0278-0232 John Wiley & Sons
    Hematological Oncology 02780232 John Wiley & Sons
    Hematological Oncology 0278-0232 Unknown
    Hematological Oncology 0278-0232 John Wiley & Sons
    Hematological Oncology 0278-0232 Wiley Blackwell
    Unknown (10991069) 10991069 Unknown